Subtype
Malignant Intestinal Neoplasm
CI-CAN-00001137Explore in graph →
1,666 active trials21 approved drugs383 evidence items
- NCIt
- C4572
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001137Explore in graph →
Clinical trials
7,771 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (772)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00297128 | Preoperative Chemoradiation With Capecitabine and Cetuximab | completed | Phase 2 | 31 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Dec 30, 2011 | clinicaltrials |
| NCT01042743 | Laparoscopic Surgery Versus Robot Surgery for Right-side Colon Cancer: Short-term Outcome of a Randomised Clinical Trial | completed | Phase 2 | 80 | Kyungpook National University HospitalOTHER | 1 | Dec 20, 2011 | clinicaltrials |
| NCT00422864 | A Single Arm Trial of Oxaliplatin and 5FU With Concurrent Radiation in Patients With Metastatic Rectal Cancer | completed | Phase 2 | 26 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Dec 15, 2011 | clinicaltrials |
| NCT00006379 | Non-Ablative Allo HSCT For Hematologic Malignancies or SAA | completed | Phase 2 | 58 | Case Comprehensive Cancer CenterOTHER | 1 | Dec 8, 2011 | clinicaltrials |
| NCT01155440 | Bowel Function After Laparoscopic Colon Surgery: Effect of IV Lidocaine | completed | Phase 2 | 60 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Nov 28, 2011 | clinicaltrials |
| NCT01477190 | Spinal Analgesia for Colonic Resection Using an Enhanced Recovery After Surgery (ERAS) Program | completed | Phase 1 / Phase 2 | 40 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Nov 28, 2011 | clinicaltrials |
| NCT00866944 | Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases(MT201-204) | completed | Phase 2 | 35 | Amgen Research (Munich) GmbHINDUSTRY | 2 | Nov 11, 2011 | clinicaltrials |
| NCT00354978 | Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients | completed | Phase 2 | 49 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 21, 2011 | clinicaltrials |
| NCT01070355 | Eicosapentaenoic Acid (EPA) for Treatment of Colorectal Cancer Liver Metastases(EMT) | completed | Phase 2 | 88 | University of LeedsOTHER | 1 | Oct 21, 2011 | clinicaltrials |
| NCT01016639 | Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer(CORGI) | completed | Phase 1 / Phase 2 | 106 | Lund University HospitalOTHER | 1 | Oct 17, 2011 | clinicaltrials |
| NCT01253837 | L19TNFα in Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 34 | Philogen S.p.A.INDUSTRY | 1 | Sep 23, 2011 | clinicaltrials |
| NCT00345696 | 1stline Study Capecitabine Administered on Continuous Way Plus Oxaliplatin&Bevacizumab Every 2weeks in Metastatic CCR. | completed | Phase 2 | 32 | Unidad Integral de Investigación en Oncología S.L.OTHER | 1 | Aug 24, 2011 | clinicaltrials |
| NCT00497263 | End-to-End Compression Anastomosis for Left-sided Colectomy Endo-CAR Study | completed | Phase 2 | — | Niti Medical Technologies Ltd.INDUSTRY | 1 | Jun 29, 2011 | clinicaltrials |
| NCT00809796 | A Safety Study of Pentamidine in Patients With Metastatic Colon Cancer Undergoing Standard Chemotherapy as Second-line and/or Third-line Treatment | completed | Phase 1 / Phase 2 | 15 | Oncozyme Pharma Inc.INDUSTRY | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00004087 | Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer | completed | Phase 1 / Phase 2 | 15 | Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyOTHER | 1 | Jun 22, 2011 | clinicaltrials |
| NCT00291785 | Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer | completed | Phase 1 / Phase 2 | 48 | CTI BioPharmaINDUSTRY | 1 | Jun 8, 2011 | clinicaltrials |
| NCT00827684 | Temsirolimus and Irinotecan for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS Mutations(TIRASMUS) | completed | Phase 2 | 50 | Vejle HospitalOTHER | 1 | Jun 8, 2011 | clinicaltrials |
| NCT00544349 | Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by Surgery | completed | Phase 2 | 45 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | May 17, 2011 | clinicaltrials |
| NCT00559741 | Cetuximab and Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer | completed | Phase 2 | 80 | Institut Cancerologie de l'OuestOTHER | 1 | May 13, 2011 | clinicaltrials |
| NCT00193167 | Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer | completed | Phase 2 | 40 | SCRI Development Innovations, LLCOTHER | 1 | May 3, 2011 | clinicaltrials |
| NCT00005049 | Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer | completed | Phase 2 | 45 | NYU Langone HealthOTHER | 1 | Apr 6, 2011 | clinicaltrials |
| NCT00004102 | Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | completed | Phase 2 | — | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00005050 | Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer | completed | Phase 1 / Phase 2 | — | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00118755 | A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 435 | Hoffmann-La RocheINDUSTRY | 0 | Mar 3, 2011 | clinicaltrials |
| NCT00192075 | A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer | completed | Phase 2 | 84 | Eli Lilly and CompanyINDUSTRY | 1 | Feb 7, 2011 | clinicaltrials |
| NCT00113776 | Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Jan 21, 2011 | clinicaltrials |
| NCT00191984 | A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal Cancer | completed | Phase 2 | 46 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 5, 2011 | clinicaltrials |
| NCT01262417 | Resorbable Barrier for the Prevention of Abdominal and Peri-hepatic Adhesion Formation(SEPRAC2T) | completed | Phase 2 | 60 | Centre Leon BerardOTHER | 1 | Dec 17, 2010 | clinicaltrials |
| NCT01251237 | Study to Assess the Tolerability, Safety and Efficacy of an Adapted Gut Cleansing Solution in Routine Colon Cleansing Prior to Colonoscopies | completed | Phase 2 | 120 | NorgineINDUSTRY | 1 | Dec 1, 2010 | clinicaltrials |
| NCT00228189 | Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients | completed | Phase 1 / Phase 2 | 30 | Radboud University Medical CenterOTHER | 1 | Nov 30, 2010 | clinicaltrials |
| NCT00386828 | Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial | completed | Phase 2 | 43 | British Columbia Cancer AgencyOTHER | 1 | Nov 25, 2010 | clinicaltrials |
| NCT00254137 | Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer. | completed | Phase 2 | 92 | Ludwig-Maximilians - University of MunichOTHER | 0 | Oct 28, 2010 | clinicaltrials |
| NCT01212718 | Response Prediction in Metastasized Colorectal Cancer Using Intratumoral Thymidylate Synthase(FOGT5) | completed | Phase 2 | 168 | University of UlmOTHER | 1 | Oct 1, 2010 | clinicaltrials |
| NCT00345761 | Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer | completed | Phase 1 / Phase 2 | 64 | Chugai PharmaceuticalINDUSTRY | 1 | Aug 16, 2010 | clinicaltrials |
| NCT01177371 | High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma | completed | Phase 2 | 13 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00005981 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 13 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 10, 2010 | clinicaltrials |
| NCT00671996 | Mangafodipir as an Adjunct to FOLFOX6 Chemotherapy in Colon Cancer Stage Dukes' C(MANFOL) | completed | Phase 2 | 14 | Egetis TherapeuticsINDUSTRY | 1 | May 4, 2010 | clinicaltrials |
| NCT01024504 | Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 46 | Hellenic Oncology Research GroupOTHER | 1 | Apr 9, 2010 | clinicaltrials |
| NCT00005804 | Bone Marrow Transplantation in Treating Patients With Hematologic Cancer | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 2, 2010 | clinicaltrials |
| NCT00285701 | Early Detection of Polyps and Colon Cancer by Fluorescence Imaging - a Dose-finding Study | completed | Phase 1 / Phase 2 | 38 | PhotocureINDUSTRY | 1 | Jan 15, 2010 | clinicaltrials |
| NCT00220116 | Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer | completed | Phase 2 | 172 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jan 6, 2010 | clinicaltrials |
| NCT00220155 | Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer | completed | Phase 2 | 16 | Royal Marsden NHS Foundation TrustOTHER | 1 | Dec 16, 2009 | clinicaltrials |
| NCT00020930 | Cetuximab in Treating Patients With Stage IV Colorectal Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 4, 2009 | clinicaltrials |
| NCT00165568 | Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer | completed | Phase 2 | 20 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 2, 2009 | clinicaltrials |
| NCT00399750 | TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer | completed | Phase 2 | 373 | SanofiINDUSTRY | 1 | Oct 15, 2009 | clinicaltrials |
| NCT00625573 | Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01)(ABX067) | completed | Phase 2 | 29 | Mt. Sinai Medical Center, MiamiOTHER | 1 | Sep 18, 2009 | clinicaltrials |
| NCT00327119 | Phase 2 Study of ABX-EGF (Panitumumab) in Japanese Subjects With M-colorectal Cancer | completed | Phase 2 | 50 | AmgenINDUSTRY | 0 | Sep 14, 2009 | clinicaltrials |
| NCT00107861 | Interferon-Beta Gene Transfer (Ad.hIFN-β) as Treatment for Refractory Colorectal Carcinoma With Liver Metastases | completed | Phase 1 / Phase 2 | 44 | BiogenINDUSTRY | 1 | Jul 14, 2009 | clinicaltrials |
| NCT00936572 | Probiotics In Colorectal Cancer Patients | completed | Phase 2 | 35 | University of Milano BicoccaOTHER | 1 | Jul 10, 2009 | clinicaltrials |
| NCT00498407 | A Phase II Study of CP-4055 as Second Line Therapy in Patients With Advanced Colorectal Cancer | completed | Phase 2 | 16 | Clavis PharmaINDUSTRY | 1 | Jun 4, 2009 | clinicaltrials |
Data updated 22 days agoSource updated Dec 30, 2011source: clinicaltrials